Jiang et al. [39] evaluated the expression levels of 174 proteins, including osteoprotegerin, in patients with ovarian cancer using antibody matrix technology and CA125 concentration by ELISA. This evidence concerns the gene TNFRSF11B and ovarian carcinoma.